Area of research
Genetics · Oncology
Research interest
Research interests include BRCA gene mutations in cancer, Cancer Immunotherapy and Biomarkers, Breast Cancer Treatment Studies, and Genetic Associations and Epidemiology.
Tamoxifen induces PI3K activation in uterine cancer
Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial
IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk
Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry
Exome sequencing identifies novel susceptibility genes and defines the contribution of coding variants to breast cancer risk
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer
Association analysis identifies 65 new breast cancer risk loci
Diabetes and Breast Cancer Subtypes
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Common germline polymorphisms associated with breast cancer-specific survival
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer
SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium
Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy
Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers
11q13 is a susceptibility locus for hormone receptor positive breast cancer
9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium